Mineralocorticoid resistance

Clinical Endocrinology

Volumn 62, Issue 5, 2005, Pages 513-520

  Geller, David S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; MINERALOCORTICOID;

CARDIOVASCULAR DISEASE; DIFFERENTIAL DIAGNOSIS; ELECTROLYTE BALANCE; GENOTYPE PHENOTYPE CORRELATION; KIDNEY TUBULE ABSORPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOHYPOALDOSTERONISM; REVIEW;

ALDOSTERONE; GENES, DOMINANT; GENES, RECESSIVE; GENOTYPE; HUMANS; HYPERTENSION; KIDNEY; MINERALOCORTICOIDS; PHENOTYPE; PSEUDOHYPOALDOSTERONISM; RECEPTORS, ALDOSTERONE; RENIN; RENIN-ANGIOTENSIN SYSTEM; SODIUM;

EID: 18444397746     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02229.x     Document Type: Review

References (65)

1. Grundy, H.M., Simpson, S.A. & Tait, J.F. (1952) Isolation of a highly active mineralocorticoid from beef adrenal extract. Nature, 169, 795-796.
2. Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J. & Gatlin, M. (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine, 348, 1309-1321.
3. Pitt, B., Zannad, F., Remme, W.J., Cody, R., Castaigne, A., Perez, A., Palensky, J. & Wittes, J. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. New England Journal of Medicine, 341, 709-717.
4. Epstein, M. (2003) Aldosterone receptor blockade and the role of eplerenone: evolving perspectives. Nephrology, Dialysis, Transplantation, 18, 1984-1992.
5. Rachmani, R., Slavachevskv, I., Amit, M., Levi, Z., Kedar, Y., Berla, M. & Ravid, M. (2004) The effect of spironolactone, cilazapril and their combination on albuminuria in patients with hypertension and diabetic nephropathy is independent of blood pressure reduction: a randomized controlled study. Diabetic Medicine, 21, 471-475.
6. Sato, A., Hayashi, K., Naruse, M. & Saruta, T. (2003) Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension, 41, 64-68.
7. Stowasser, M. & Gordon, R.D. (2004) Primary aldosteronism - careful investigation is essential and rewarding. Molecular and Cellular Endocrinology, 217, 33-39.
8. Juurlink, D.N., Mamdani, M.M., Lee, D.S., Kopp, A., Austin, P.C., Laupacis, A. & Redelmeier, D.A. (2004) Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. New England Journal of Medicine, 351, 543-551.
9. Brilla, C.G. (2000) Renin-angiotensin-aldosterone system and myocardial fibrosis. Cardiovascular Research, 47, 1-3.
10. Brilla, C.G., Pick, R., Tan, L.B., Janicki, J.S. & Weber, K.T. (1990) Remodeling of the rat right and left ventricles in experimental hypertension. Circulation Research, 67, 1355-1364.
11. Brilla, C.G. & Weber, K.T. (1992) Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovascular Research, 26, 671-677.
12. Cheek, D. & Perry, J. (1958) A salt wasting syndrome in infancy. Archives of Disease in Childhood, 252, 256.
13. Armanini, D., Kuhnle, U., Strasser, T., Dorr, H., Butenandt, I., Weber, P.C., Stockigt, J.R., Pearce, P. & Funder, J.W. (1985) Aldosterone-receptor deficiency in pseudohypoaldosteronism. New England Journal of Medicine, 313, 1178-1181.
14. Arai, K., Tsigos, C., Suzuki, Y., Listwak, S., Zachman, K., Zangeneh, F., Rapaport, R., Chanoine, J.P. & Chrousos, G.P. (1995) No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism. Journal of Clinical Endocrinology and Metabolism, 80, 814-817.
15. Komesaroff, P.A. (1995) Pseudohypoaldosteronism: options for consideration. Steroids, 60, 168-172.
16. Zennaro, M.C., Borensztein, P., Jeunemaitre, X., Armanini, D. & Soubrier, F. (1994) No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. Journal of Clinical Endocrinology and Metabolism, 79, 32-38.
17. Hanukoglu, A. (1991) Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. Journal of Clinical Endocrinology and Metabolism, 73, 936-944.
18. Chang, S.S., Grunder, S., Hanukoglu, A., Rosler, A., Mathew, P.M., Hanukoglu, I., Schild, L., Lu, Y., Shimkets, R.A., Nelson-Williams, C., Rossier, B.C. & Lifton, R.P. (1996) Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type I. Nature Genetics, 12, 248-253.
19. Strautnieks, S.S., Thompson, R.J., Gardiner, R.M. & Chung, E. (1996) A novel splice-site mutation in the gamma subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nature Genetics, 13, 248-250.
20. Thomas, C.P., Zhou, J., Liu, K.Z., Mick, V.E., MacLaughlin, E. & Knowles, M. (2002) Systemic pseudohypoaldosteronism from deletion of the promoter region of the human beta epithelial Na(+) channel subunit. American Journal of Respiratory Cell and Molecular Biology, 27, 314-319.
21. + metabolism. Proceedings of the National Academy of Sciences of the United States of America, 95, 9424-9429.
22. Kerem, E., Bistritzer, T., Hanukoglu, A., Hofmann, T., Zhou, Z., Bennett, W., MacLaughlin, E., Barker, P., Nash, M., Quittell, L., Boucher, R. & Knowles, M.R. (1999) Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. New England Journal of Medicine, 341, 156-162.
23. Hummler, E., Barker, P., Talbot, C., Wang, Q., Verdumo, C., Grubb, B., Gatzy, J., Burnier, M., Horisberger, J.D., Beermann, F., Boucher, R. & Rossier, B.C. (1997) A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism. Proceedings of the National Academy of Sciences of the United States of America, 94, 11710-11715.
24. + channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proceedings of the National Academy of Sciences of the United States of America, 96, 1727-1731.
25. Barker, P.M., Nguyen, M.S., Gatzy, J.T., Grubb, B., Norman, H., Hummler, E., Rossier, B., Boucher, R.C. & Koller, B. (1998) Role of gammaENaC subunit in lung liquid clearance and electrolyte balance in newborn mice. Insights into perinatal adaptation and pseudohypoaldosteronism. Journal of Clinical Investigation, 102, 1634-1640.
26. + channel, ROMK. Nature Genetics, 14, 152-156.
27. Finer, G., Shalev, H., Birk, O.S., Galron, D., Jeck, N., Sinai-Treiman, L. & Landau, D. (2003) Transient neonatal hyperkalemia in the antenatal (ROMK defective) Bartter syndrome. Journal of Pediatrics, 142, 318-323.
28. Simon, D.B., Karet, F.E., Hamdan, J.M., DiPietro, A., Sanjad, S.A. & Lifton, R.P. (1996) Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nature Genetics, 13, 183-188.
29. Simon, D.B., Nelson-Williams, C., Bia, M.J., Ellison, D., Karet, F.E., Molina, A.M., Vaara, I., Iwata, F., Cushner, H.M., Koolen, M., Gainza, F.J., Gitleman, H.J. & Lifton, R.P. (1996c) Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nature Genetics, 12, 24-30.
30. Cruz, D.N., Simon, D.B., Nelson-Williams, C., Farhi, A., Finberg, K., Burleson, L., Gill, J.R. & Lifton, R.P. (2001) Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension, 37, 1458-1464.
31. + exchanger but not in mice lacking NHE2. American Journal of Physiology. Renal Physiology, 281, F718-F727.
32. + exchanger. Nature Genetics, 19, 282-285.
33. Lorenz, J.N., Schultheis, P.J., Traynor, T., Shull, G.E. & Schnermann, J. (1999) Micropuncture analysis of single-nephron function in NHE3-deficient mice. American Journal of Physiology, 277, F447-F453.
34. Frindt, G. & Palmer, L.G. (2004) Na channels in the rat connecting tubule. American Journal of Physiology. Renal Physiology, 286, F669-F674.
35. Rubera, I., Loffing, J., Palmer, L.G., Frindt, G., Fowler-Jaeger, N., Sauter, D., Carroll, T., McMahon, A., Hummler, E. & Rossier, B.C. (2003) Collecting duct-specific gene inactivation of alphaENaC in the mouse kidney does not impair sodium and potassium balance. Journal of Clinical Investigation, 112, 554-565.
36. Geller, D.S., Rodriguez-Soriano, J., Vallo Boado, A., Schifter, S., Bayer, M., Chang, S.S. & Lifton, R.P. (1998) Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nature Genetics, 19, 279-281.
37. Huey, C.L., Riepe, F.G., Sippell, W.G. & A.S. (2004) Genetic heterogeneity in autosomal dominant pseudohypoaldosteronism type I: exclusion of claudin-8 as a candidate gene. American Journal of Nephrology, 24, 483-487.
38. Viemann, M., Peter, M., Lopez-Siguero, J.P., Simic-Schleicher, G. & Sippell, W.G. (2001) Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds. Journal of Clinical Endocrinology and Metabolism, 86, 2056-2059.
39. Sartorato, P., Khaldi, Y., Lapeyraque, A.L., Armanini, D., Kuhnle, U., Salomon, R., Caprio, M., Viengchareun, S., Lombes, M. & Zermaro, M.C. (2004) Inactivating mutations of the mineralocorticoid receptor in type I pseudohypoaldosteronism. Molecular and Cellular Endocrinology, 217, 119-125.
40. Hentze, M.W. & Kulozik, A.E. (1999) A perfect message: RNA surveillance and nonsense-mediated decay. Cell, 96, 307-310.
41. Tajima, T., Kitagawa, H., Yokoya, S., Tachibana, K., Adachi, M., Nakae, J., Suwa, S., Katoh, S. & Fujieda, K. (2000) A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. Journal of Clinical Endocrinology and Metabolism, 85, 4690-4694.
42. Morton, J.A. (1994) The clinical usefulness of breast milk sodium in the assessment of lactogenesis. Pediatrics, 93, 802-806.
43. Neville, M.C., Keller, R., Seacat, J., Lutes, V., Neifert, M., Casey, C., Allen, J. & Archer, P. (1988) Studies in human lactation: milk volumes in lactating women during the onset of lactation and full lactation. American Journal of Clinical Nutrition, 48, 1375-1386.
44. Benchimol, C., Zavilowitz, B. & Satlin, L.M. (2000) Developmental expression of ROMK mRNA in rabbit cortical collecting duct. Pediatrics Research, 47, 46-52.
45. Disse-Nicodeme, S., Achard, J.M., Desitter, I., Houot, A.M., Fournier, A., Corvol, P. & Jeunemaitre, X. (2000) A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. American Journal of Human Genetics, 67, 302-310.
46. Wilson, F.H., Disse-Nicodeme, S., Choate, K.A., Ishikawa, K., Nelson-Williams, C., Desitter, I., Gunel, M., Milford, D.V., Lipkin, G.W., Achard, J.M., Feely, M.P., Dussol, B., Berland, Y., Unwin, R.J., Mayan, H., Simon, D.B., Farfel, Z., Jeunemaitre, X. & Lifton, R.P. (2001) Human hypertension caused by mutations in WNK kinases. Science, 293, 1107-1112.
47. Wilson, F.H., Kahle, K.T., Sabath, E., Lalioti, M.D., Rapson, A.K., Hoover, R.S., Hebert, S.C., Gamba, G. & Lifton, R.P. (2003) Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4. Proceedings of the National Academy of Sciences of the United States of America, 100, 680-684.
48. Yang, C.L., Angell, J., Mitchell, R. & Ellison, D.H. (2003) WNK kinases regulate thiazide-sensitive Na-Cl cotransport. Journal of Clinical Investigation, 111, 1039-1045.
49. + secretion. Nature Genetics, 35, 372-376.
50. Pearce, D. (2003) SGK1 regulation of epithelial sodium transport. Cellular Physiology and Biochemistry, 13, 13-20.
51. Wulff, P., Vallon, V., Huang, D.Y., Volkl, H., Yu, F., Richter, K., Jansen, M., Schlunz, M., Klingel, K., Loffing, J., Kauselmann, G., Bosl, M.R., Lang, F. & Kuhl, D. (2002) Impaired renal Na(+) retention in the sgk1-knockout mouse. Journal of Clinical Investigation, 110, 1263-1268.
52. Kuhnle, U., Guariso, G., Sonega, M., Hinkel, G.K., Hubl, W. & Armanini, D. (1993) Transient pseudohypoaldosteronism in obstructive renal disease with transient reduction of lymphocytic aldosterone receptors. Results in two affected infants. Hormone Research, 39, 152-155.
53. Schoen, E.J., Bhatia, S., Ray, G.T., Clapp, W. & To, T.T. (2002) Transient pseudohypoaldosteronism with hyponatremia-hyperkalemia in infant urinary tract infection. Journal of Urology, 167, 680-682.
54. Bantle, J.P., Nath, K.A., Sutherland, D.E., Najarian, J.S. & Ferris, T.F. (1985) Effects of cyclosporine on the renin-angiotensin-aldosterone system and potassium excretion in renal transplant recipients. Archives of Internal Medicine, 145, 505-508.
55. Kamel, K.S., Ethier, J.H., Quaggin, S., Levin, A., Albert, S., Carlisle, E.J. & Halperin, M.L. (1992) Studies to determine the basis for hyperkalemia in recipients of a renal transplant who are treated with cyclosporine. Journal of the American Society of Nephrology, 2, 1279-1284.
56. Deppe, C.E., Heering, P.J., Viengchareun, S., Grabensee, B., Farman, N. & Lombes, M. (2002) Cyclosporine A and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology, 143, 1932-1941.
57. Heering, P.J., Klein-Vehne, N. & Fehsel, K. (2004) Decreased mineralocorticoid receptor expression in blood cells of kidney transplant recipients undergoing immunosuppressive treatment: cost efficient determination by quantitative PCR. Journal of Clinical Pathology, 57, 33-36.
58. Heering, P.J., Kurschat, C., Vo, D.T., Klein-Vehne, N., Fehsel, K. & Ivens, K. (2004) Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression. Clinical Transplantation, 18, 186-192.
59. Brilla, C.G. (2000) Renin-angiotensin system mediated mechanisms: cardioreparation and cardioprotection. Heart, 84, i18-i19.
60. Losel, R., Schultz, A., Boldyreff, B. & Wehling, M. (2004) Rapid effects of aldosterone on vascular cells: clinical implications. Steroids, 69, 575-578.
61. Rocha, R., Chander, P.N., Khanna, K., Zuckerman, A. & Stier, C.T. Jr (1998) Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension, 31, 451-458.
62. Rocha, R., Martin-Berger, C.L., Yang, P., Scherrer, R., Delyani, J. & McMahon, E. (2002) Selective aldosterone blockade prevents angiotensin 11/salt-induced vascular inflammation in the rat heart. Endocrinology, 143, 4828-4836.
63. Rocha, R., Stier, CT. Jr, Kifor, I., Ochoa-Maya, M.R., Rennke, H.G., Williams, G.H. & Adler, G.K. (2000) Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology, 141, 3871-3878.
64. Sepehrdad, R., Chander, P.N., Oruene, A., Rosenfeld, L., Levine, S. & Stier, C.T. Jr (2003) Amiloride reduces stroke and renal injury in stroke-prone hypertensive rats. American Journal of Hypertension, 16, 312-318.
65. Lal, A., Veinot, J.P. & Leenen, F.H. (2003) Prevention of high salt diet-induced cardiac hypertrophy and fibrosis by spironolactone. American Journal of Hypertension, 16, 319-323.